Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease acute myocardial infarction
Symptom C0011847|diabetes
Sentences 16
PubMedID- 20205960 Hospital admissions by acute myocardial infarction among subjects with or without diabetes for years 2001-2006.
PubMedID- 23226370 Background: although the clinical outcome of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) is well established to be worse than for non-diabetic patients, the reasons for this remain unclear.
PubMedID- 24934236 Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum.
PubMedID- 24399329 Risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus.
PubMedID- 24708579 Pioglitazone also reduced the risk of hospitalization for acute myocardial infarction in patients with type 2 diabetes in comparison with rosiglitazone .
PubMedID- 25671950 The objective of study was to determine the frequency of newly diagnosis diabetes presenting with acute myocardial infarction.
PubMedID- 24843443 Furthermore, anemia is accompanied by cardiovascular events9–12, mortality13 and mortality after acute myocardial infarction16 in patients with diabetes mellitus.
PubMedID- 26209521 Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus.
PubMedID- 21447495 Serum resistin in acute myocardial infarction patients with and without diabetes mellitus.
PubMedID- 26279482 Aims: to assess the risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus treated with long-acting insulin analogues in comparison with other basal insulin therapy.
PubMedID- 20484611 Recent meta-analyses suggest an increased risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) treated with rosiglitazone.
PubMedID- 24529823 Glycemic variability predicts cardiovascular complications in acute myocardial infarction patients with type 2 diabetes mellitus.
PubMedID- 22343257 Background: the impact of diabetes in patients with acute myocardial infarction (ami) treated with primary percutaneous coronary intervention (pci) is unclear.
PubMedID- 23270530 Showed that acute myocardial infarction (mi) patients with igt or diabetes exhibited higher levels of high-sensitivity c-reactive protein and interleukin-6 levels compared with acute mi patients with normal glucose tolerance or well-controlled diabetes, indicating that glycol metabolism in acute mi is associated with acute stress and inflammation.
PubMedID- 22763393 In particular, further studies focusing on the risk of acute myocardial infarction in patients with diabetes treated with intravitreal vascular endothelial growth factor inhibitors are warranted.
PubMedID- 26180535 Studies were excluded if (1) animals; (2) review and case report; (3) study focused on specific cad population, for example, female cad patients, acute myocardial infarction, cad with diabetes, and so on (4) duplicate reports.

Page: 1